Identification of embelin, a 3‐undecyl‐1,4‐benzoquinone from Embelia ribes as a multitargeted anti‐Alzheimer agent

VK Nuthakki, A Sharma, A Kumar… - Drug Development …, 2019 - Wiley Online Library
Abstract Beta‐secreatse (BACE‐1) and cholinesterases are clinically validated targets of
Alzheimer's disease (AD), for which natural products have provided immense contribution …
被引用次数：48 相关文章

Identification of embelin, a 3-undecyl-1, 4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.

VK Nuthakki, A Sharma, A Kumar… - Drug Development …, 2019 - europepmc.org
Beta-secreatse (BACE-1) and cholinesterases are clinically validated targets of Alzheimer's
disease (AD), for which natural products have provided immense contribution. The …

Identification of embelin, a 3-undecyl-1, 4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent

VK Nuthakki, A Sharma, A Kumar… - Drug development …, 2019 - pubmed.ncbi.nlm.nih.gov
Beta-secreatse (BACE-1) and cholinesterases are clinically validated targets of Alzheimer's
disease (AD), for which natural products have provided immense contribution. The …

Identification of embelin, a 3‐undecyl‐1, 4‐benzoquinone from Embelia ribes as a multitargeted anti‐Alzheimer agent.

VK Nuthakki, A Sharma, A Kumar… - Drug Development …, 2019 - search.ebscohost.com
Abstract Beta‐secreatse (BACE‐1) and cholinesterases are clinically validated targets of
Alzheimer's disease (AD), for which natural products have provided immense contribution …

Identification of embelin, a 3‐undecyl‐1,4‐benzoquinone from Embelia ribes as a multitargeted anti‐Alzheimer agent

VK Nuthakki, A Sharma, A Kumar… - Drug Development …, 2019 - Wiley Online Library
Abstract Beta‐secreatse (BACE‐1) and cholinesterases are clinically validated targets of
Alzheimer's disease (AD), for which natural products have provided immense contribution …

Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.

VK Nuthakki, A Sharma, A Kumar, SB Bharate - 2019 - cabidigitallibrary.org
Abstract Beta-secreatse (BACE-1) and cholinesterases are clinically validated targets of
Alzheimer's disease (AD), for which natural products have provided immense contribution …